检索结果-南通市图书馆

Unpacking the Relationship Between Teachers’Perceptions of Professional Learning Communities and Differentiated Instruction Practice

引用

ECNU Review of Education 2020年第4期3卷 694-714页

作者： sally wai-yan wan Department of Curriculum and Instruction Faculty of EducationThe Chinese University of Hong KongShatinNTHong Kong SARChina

Purpose:This exploratory study investigates the relationship between teachers’perceptions of professional learning communities(PLCs)and their differentiated instruction(DI)practice in a Hong Kong primary education ***/Approach/Methods:Three subsidized primary schools participated in the study.A total of 121 teachers completed surveys regarding their perceptions of PLC engagement and DI ***:Using principal component analysis,three dimensions of PLC engagement were identified:student learning,reflective dialogue,and shared and supportive *** distinctive PLC engagement profiles were generated based on cluster analysis:high PLC engagement and low PLC ***’PLC engagement profiles were correlated with their DI ***/Value:The findings have implications for fostering teacher engagement in *** teacher participation in PLCs has great potential for promoting the use of DI.

关键词： Cluster analysis differentiated instruction(DI) Hong Kong professional learning communities(PLCs) teacher leadership

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Validation of an objective scar pigmentation measurement by using a spectrocolorimeter

Validation of an objective scar pigmentation measurement by ...

引用

第八届全国烧伤外科学年会

作者： Cecilia W．P．Li-Tsang Joy C．M．Lau sally K．Y．Liu Department of Rehabilitation Sciences The Hong Kong Polytechnic UniversityHung HomKowloonHong KongPR China Occupational Therapy Department Pamela Youde Nethersole Eastern HospitalHospital AuthorityChai WanHong KongPR China

＜正＞Scar pigmentation changes throughout its maturation process and it is often used as one of the indicators for scar maturation,yet it is often rated *** purpose of this study was to investigate the application of a commercial spectrocolorimeter to produce a reliable measurement on scar *** Internationale de l’Eclairage （CIE） model of color has been adopted in this study for measurement of scar pigmentation 24 patients with hypertrophic scars at different stages of maturation were selected for the study,were inspected by two therapists using the Vancouver scar scale （VSS） and then using spectrocolorimeter for inter-rater *** measurements were taken after 30 min by the same group of therapists （test-retest reliability）.Results indicated that the inter-rater reliability among the three therapists was satisfactory,with intra-class correlation coefficient （ICC）（2,2） from 0.50 to 0.99 in all the three color *** test-retest reliability of the spectrocolorimeterwas satisfactory with ICC （3,6） ranged from 0.95 to *** difference was also noted between the measurements of normal skin and hypertrophic scar （P＜0.00,t-values:from 2.78 to 0.05,d.f.:from 29.7 to 46.00） in all color parameters,except the chroma C*.We also found a positive relationship between VSS scores and the spectrocolorimeter *** spectrocolorimeter is found to be a reliable instrument to quantify scar pigmentation and to differentiate normal skin and scar *** further studies,the constructs of scar properties could further be explored using this spectrocolorimeter. 2003 Elsevier Ltd and *** rights reserved.

关键词：

来源： cnki会议评论

在线全文

cnki会议

学校读者我要写书评

暂无评论

Real-world Effectiveness and Tolerability of Interferonfree Direct-acting Antiviral for 15,849 Patients with Chronic Hepatitis C:A Multinational Cohort Study

引用

Journal of Clinical and Translational Hepatology 2024年第7期12卷 646-658页

作者： Fanpu Ji sally Tran Eiichi Ogawa Chung-Feng Huang Takanori Suzuki Yu Jun Wong Hidenori Toyoda Dae Won Jun Liu Li Haruki Uojima Akito Nozaki Makoto Chuma Cheng-Hao Tseng Yao-Chun Hsu Masatoshi Ishigami Takashi Honda Masanori Atsukawa Hiroaki Haga Masaru Enomoto Huy Trinh Carmen Monica Preda Phillip Vutien Charles Landis Dong Hyun Lee Tsunamasa Watanabe Hirokazu Takahashi Hiroshi Abe Akira Asai Yuichiro Eguchi Jie Li Xiaozhong wang Jia Li Junping Liu Jing Liang Carla Pui-Mei Lam Rui Huang Qing Ye Hongying Pan Jiajie Zhang Dachuan Cai Qi wang Daniel Q.Huang Grace Wong Vincent wai-Sun Wong Junyi Li Son Do Norihiro Furusyo Makoto Nakamuta Hideyuki Nomura Eiji Kajiwara Eileen L.Yoon Sang Bong Ahn Koichi Azuma Kazufumi Dohmen Jihyun An Do Seon Song Hyun Chin Cho Akira Kawano Toshimasa Koyanagi Aritsune Ooho Takeaki Satoh Kazuhiro Takahashi Ming-Lun Yeh Pei-Chien Tsai Satoshi Yasuda Yunyu Zhao Yishan Liu Tomomi Okubo Norio Itokawa Mi Jung Jun Toru Ishikawa Koichi Takaguchi Tomonori Senoh Mingyuan Zhang Changqing Zhao Raluca Ioana Alecu Wei Xuan Tay Pooja Devan Joanne Kimiko Liu Ritsuzo Kozuka Elena Vargas-Accarino Ai-Thien Do Mayumi Maeda wan-Long Chuang Jee-Fu Huang Chia-Yen Dai Ramsey Cheung Maria Buti Junqi Niu Wen Xie Hong Ren Seng Gee Lim Chao Wu Man-Fung Yuen Jia Shang Qiang Zhu Yoshiyuki Ueno Yasuhito Tanaka Jun Hayashi Ming-Lung Yu Mindie H.Nguyen Department of Infectious Diseases The Second Affiliated Hospital of Xi’an Jiaotong UniversityXi’anShaanxiChina Division of Gastroenterology and Hepatology Department of MedicineStanford University Medical CenterPalo AltoCAUSA Department of General Internal Medicine Kyushu University HospitalFukuokaJapan Hepatobiliary Division Department of Internal MedicineKaohsiung Medical University HospitalKaohsiung Hepatitis Research Center College of Medicine and Center for Liquid Biopsy and Cohort ResearchKaohsiung Medical UniversityKaohsiung Department of Gastroenterology and Metabolism Nagoya City University Graduate School of Medical SciencesNagoyaJapan Gastroenterology&Hepatology Changi General HospitalSinghealthSingapore Singhealth Duke-NUS Medicine Academic Clinical Program Singapore Department of Gastroenterology Ogaki Municipal HospitalOgakiJapan Department of Internal Medicine Hanyang UniversityCollege of MedicineSeoulKorea Hanyang Institute of Bioscience and Biotechnology Hanyang UniversitySeoulKorea Department of Hepatology The Third People's Hospital of Kunming CityKunmingYunnanChina Department of Gastroenterology Internal MedicineKitasato University School of MedicineSagamiharaJapan Gastroenterological Center Yokohama City University Medical CenterYokohamaJapan Division of Gastroenterology and Hepatology Department of Internal MedicineE-Da Cancer HospitalKaohsiung Department of Gastroenterology and Hepatology Nagoya University Graduate School of MedicineNagoyaJapan Division of Gastroenterology and Hepatology Nippon Medical SchoolTokyoJapan Department of Gastroenterology Yamagata University Faculty of MedicineYamagataJapan Department of Transfusion Medicine and Department of Hepatology Osaka Metropolitan University Graduate School of MedicineOsakaJapan San Jose Gastroenterology San JoseCAUSA Gastroenterology&Hepatology Department Clinic Fundeni InstituteBucharestRomania Division of Gastroenterology and Hepatology University of WashingtonSeattleWAUSA Department of

Background and Aims:As practice patterns and hepatitis C virus(HCV)genotypes(GT)vary geographically,a global real-world study from both East and West covering all GTs can help inform practice policy toward the 2030 HCV elimination *** study aimed to assess the effectiveness and tolerability of DAA treatment in routine clinical practice in a multinational cohort for patients infected with all HCV GTs,focusing on GT3 and ***:We analyzed the sustained virological response(SVR12)of 15,849 chronic hepatitis C patients from 39 Real-World Evidence from the Asia Liver Consortium for HCV clinical sites in Asia Pacific,North America,and Europe between 07/01/2014–07/01/***:The mean age was 62±13 years,with 49.6%*** demographic breakdown was 91.1%Asian(52.9%Japanese,25.7%Chinese/Taiwan residents,5.4%Korean,3.3%Malaysian,and 2.9%Vietnamese),6.4%White,1.3%Hispanic/Latino,and 1%Black/***,34.8%had cirrhosis,8.6%had hepatocellular carcinoma(HCC),and 24.9%were treatment-experienced(20.7%with interferon,4.3%with direct-acting antivirals).The largest group was GT1(10,246[64.6%]),followed by GT2(3,686[23.2%]),GT3(1,151[7.2%]),GT6(457[2.8%]),GT4(47[0.3%]),GT5(1[0.006%]),and untyped GTs(261[1.6%]).The overall SVR12 was 96.9%,with rates over 95%for GT1/2/3/6 but 91.5%for ***12 for GT3 was 95.1%overall,98.2%for GT3a,and 94.0%for ***12 was 98.3%overall for GT6,lower for patients with cirrhosis and treatment-experienced(TE)(93.8%)but≥97.5%for tretment-naive patients regardless of cirrhosis *** multivariable analysis,advanced age,prior treatment failure,cirrhosis,active HCC,and GT3/4 were independent predictors of lower SVR12,while being Asian was a significant predictor of achieving ***:In this diverse multinational realworld cohort of patients with various GTs,the overall cure rate was 96.9%,despite large numbers of patients with cirrhosis,HCC,TE,and GT3/***12 for GT3/6 with cirrhosis and TE was lower but st

关键词： Hepatitis C virus Liver cirrhosis Hepatocellular carcinoma Genotype DAA REAL-C

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

基于“四位一体”的大学生法治观念培育路径研究

引用

山东农业工程学院学报 2017年第4期34卷 127-128页

作者：林候杨万红厦门理工学院经济与管理学院福建厦门361024 厦门东海职业技术学院福建厦门361100

十八届四中全会吹响全面推进依法治国的号角,大学生作为社会主义现代化建设的生力军,提高其法治观念是全民法治的重要突破口。探索构建家庭、学校、社会、自身"四位一体"的大学生法治观念的养成路径,以期为相关部门促进全民守法,推动全... 详细信息

十八届四中全会吹响全面推进依法治国的号角,大学生作为社会主义现代化建设的生力军,提高其法治观念是全民法治的重要突破口。探索构建家庭、学校、社会、自身"四位一体"的大学生法治观念的养成路径,以期为相关部门促进全民守法,推动全社会树立法治意识,推动法治社会的建设提供具有可操作性的对策和建议。

关键词：四位一体法治观念培育路径

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

SALIRI-based(raltitrexed plus irinotecan)therapy as a second-line treatment for patients with metastatic colorectal cancer(sally):A prospective,multicenter,non-interventional,registry study

引用

Cancer Communications 2024年第8期44卷 910-914页

作者： Shuqui Qin Jin Li Aiping Zhou yanqiao Zhang Xianglin Yuan Liangjun Zhu Baoli Qin Shan Zeng Lin Shen Ying Yuan Weibo wang Jun Liang Xianwen Zhang Feng Ye Ping Chen Huaizhangwang Zhenyan Yu Lu Yue Yong Fang Jianping Xiong Jianwei yang Yiye wan Xianli Yin Wenling wang Nong Xu Xiaohongwang Zemin Xiao Huafang Su Yingwang Kangsheng Gu Shuiping Tu Zishu wang Bo Liu Xiaohua Hu Weixian Liu Xiaofeng Li Department of Oncology Nanjing Tianyinshan HospitalNanjingJiangsuP.R.China Department of Medical Oncology Shanghai East HospitalShanghaiP.R.China Department of Medical Oncology Cancer Hospital Chinese Academy of Medical SciencesBeijingP.R.China Department of Gastroenterology Harbin Medical University Cancer HospitalHarbinHeilongjiangP.R.China Department of Medical Oncology Tongji HospitalTongji Medical CollegeHuazhong University of Science and TechnologyWuhanHubeiP.R.China Department of Medical Oncology Jiangsu Cancer HospitalNanjingJiangsuP.R.China Department of Gastroenterology Liaoning Cancer Hospital&InstituteShenyangLiaoningP.R.China Department of Oncology Xiangya HospitalCentral South UniversityChangshaHunanP.R.China Department of Medical Oncology Beijing Cancer HospitalBeijingP.R.China Department of Medical Oncology The Second Affiliated HospitalZhejiang University School of MedicineHangzhouZhejiangP.R.China Department of Chemotherapy Shandong Provincial HospitalJinanShandongP.R.China Department of Medical Oncology Peking University International HospitalBeijingP.R.China Department of Medical Oncology Northern Jiangsu People’s HospitalYangzhouJiangsuP.R.China Department of Medical Oncology The First Affiliated Hospital of Xiamen UniversityXiamenFujianP.R.China Department of Medical Oncology General Hospital of NingxiaMedical UniversityYinchuanNingxiaP.R.China Department of Integrated Chinese andWestern Medicine Henan Cancer HospitalZhengzhouHenanP.R.China Department of Medical Oncology Mudanjiang Tumor HospitalMudanjiangHeilongjiangP.R.China Department of Oncology Qingdao Municipal Hospital(Group)QingdaoShandongP.R.China Department of Medical Oncology Sir Run Run Shaw HospitalZhejiang University School of MedicineHangzhouZhejiangP.R.China Department of Medical Oncology The First Affiliated Hospital of Nanchang UniversityNanchangJiangxiP.R.China Department of Abdominal Oncology Fujian Cancer HospitalFuzhouFujianP.R.China Department of Gastroent

Primary chemotherapy options for colorectal cancer(CRC)involve four key drugs:fluorouracils(5-FU),oxaliplatin,irinotecan and *** first-line regimen consists of 5-FU and leucovorin combined with oxaliplatin(FOLFOX),while the second-line regimen involves 5-FU and leucovorin combined with irinotecan(FOLFIRI)for metastatic CRC(mCRC)in China[1].

关键词： drugs chemotherapy FOLFIRI

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

欢迎您,

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

在线全文

在线全文

请选择保存的检索档案：

请选择收藏分类：

通借通还

欢迎您,

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

在线全文

在线全文

在线全文

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：